New heart-on-a-chip could eventually lead to elimination of laboratory animals in drug testing, while also lowering the cost of drug development.
A new device that simulates the human heart will spare some animals from medical drug testing.
The new heart-on-a-chip developed by researchers at UC Berkeley, hosts live, beating heart cells and is a major advancement for medical science. Professor Kevin Healy says his device is a more efficient, accurate and less expensive method for testing cardiac drugs.
Typically, human subjects are too weak to undergo clinical trials, so animals have been substituted. But, this practice is also known to cause high failure rates in predicting human reactions.
“It takes about $5 billion on average to develop a drug, and 60 percent of that figure comes from upfront costs in the research and development phase. Using a well-designed model of a human organ could significantly cut the cost and time of bringing a new drug to market.”
Pulsating cardiac muscle cells made from adult stem cells are placed in the device, which copies the 3D structure of how cells grow in the heart. Within 24 hours after the heart cells were loaded into the chamber, they began beating on their own at a normal rate. The engineered tissue remained functional for several weeks.
Healy hopes this process will be used to test various drugs and eliminate animal subjects all together in the future.
See the pulsating heart-on-a-chip in action in this short clip below:
(Learn more at UC Berkeley)